人工智能系统在乳腺X线筛查间期乳腺癌检测中的准确性
该研究回顾性分析2011年1月至2018年12月由两名人类阅片者评估的2052幅筛查乳腺X线图像(514例间期癌和1548幅正常图像),使用商业人工智能系统评估其对间期癌的定位能力。结果显示,在96%特异度阈值下,AI标记了23.5%的间期癌并正确定位其中76.9%,且对淋巴结阳性癌的定位比例高于淋巴结阴性癌(P = .03)。
要点
- 在96%特异度阈值下,AI标记23.5%的间期癌,其中76.9%定位正确。
- AI对真阴性间期癌的定位比例(12.6%)低于微小恶性征象(46%)和假阴性间期癌(50%)。
- AI对淋巴结阳性癌的定位比例高于淋巴结阴性癌(P = .03),其他病理特征无差异。
核心结论
- 使用独立AI系统可通过正确识别部分被两名人类阅片者漏诊的癌症来改善早期癌症检测,除淋巴结阳性癌外,不同组织病理学特征间无差异。
研究设计与样本
- 回顾性分析2011年1月至2018年12月由两名人类阅片者评估的筛查乳腺X线数据,使用商业AI系统分析,中位患者年龄57岁(IQR 52-64岁)。
诊断标准与关键数值
- AI输出为病灶位置热图和每病灶最高风险评分(范围0-100);AI热图出现在正常筛查乳腺X线或间期癌筛查乳腺X线但位于癌症边界外视为假阳性。
临床应用与阅片要点
- 在96%特异度阈值下,AI算法标记514例间期癌中的121例(23.5%),并在121例中正确定位93例(76.9%),间期癌乳腺X线上出现48个假阳性热图(每例率0.093),正常乳腺X线上出现74个假阳性热图(每例率0.048)。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
Background Artificial intelligence (AI) systems can be used to identify interval breast cancers, although the localizations are not always accurate. Purpose To evaluate AI localizations of interval cancers (ICs) on screening mammograms by IC category and histopathologic characteristics. Materials and Methods A screening mammography data set (median patient age, 57 years [IQR, 52-64 years]) that had been assessed by two human readers from January 2011 to December 2018 was retrospectively analyzed using a commercial AI system. The AI outputs were lesion locations (heatmaps) and the highest per-lesion risk score (range, 0-100) assigned to each case. AI heatmaps were considered false positive (FP) if they occurred on normal screening mammograms or on IC screening mammograms (ie, in patients subsequently diagnosed with IC) but outside the cancer boundary. A panel of consultant radiology experts classified ICs as normal or benign (true negative [TN]), uncertain (minimal signs of malignancy [MS]), or suspicious (false negative [FN]). Several specificity and sensitivity thresholds were applied. Mann-Whitney U tests, Kruskal-Wallis tests, and χ2 tests were used to compare groups. Results A total of 2052 screening mammograms (514 ICs and 1548 normal mammograms) were included. The median AI risk score was 50 (IQR, 32-82) for TN ICs, 76 (IQR, 41-90) for ICs with MS, and 89 (IQR, 81-95) for FN ICs (P = .005). Higher median AI scores were observed for invasive tumors (62 [IQR, 39-88]) than for noninvasive tumors (33 [IQR, 20-55]; P < .01) and for high-grade (grade 2-3) tumors (62 [IQR, 40-87]) than for low-grade (grade 0-1) tumors (45 [IQR, 26-81]; P = .02). At the 96% specificity threshold, the AI algorithm flagged 121 of 514 (23.5%) ICs and correctly localized the IC in 93 of 121 (76.9%) cases, with 48 FP heatmaps on the mammograms for ICs (rate, 0.093 per case) and 74 FP heatmaps on normal mammograms (rate, 0.048 per case). The AI algorithm correctly localized a lower proportion of TN ICs (54 of 427; 12.6%) than ICs with MS (35 of 76; 46%) and FN ICs (four of eight; 50% [95% CI: 13, 88]; P < .001). The AI algorithm localized a higher proportion of node-positive than node-negative cancers (P = .03). However, no evidence of a difference by cancer type (P = .09), grade (P = .27), or hormone receptor status (P = .12) was found. At 89.8% specificity and 79% sensitivity thresholds, AI detection increased to 181 (35.2%) and 256 (49.8%) of the 514 ICs, respectively, with FP heatmaps on 158 (10.2%) and 307 (19.8%) of the 1548 normal mammograms. Conclusion Use of a standalone AI system improved early cancer detection by correctly identifying some cancers missed by two human readers, with no differences based on histopathologic features except for node-positive cancers. © RSNA, 2024 Supplemental material is available for this article.
引用
- Nanaa M, Gupta VO, Hickman SE, et al. Accuracy of an Artificial Intelligence System for Interval Breast Cancer Detection at Screening Mammography. Radiology. 2024. PMID: 39189901. doi:10.1148/radiol.232303
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。